HY-N10898-1mg
|
MedChemexpress LLC
|
(-)-Dihydroguaiaretic acid [CAS 124649-78-1]
|
|
|
|
HY-134978B-1mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978B-10mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978B-100mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978B-25mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978B-5mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978B-50mg
|
MedChemexpress LLC
|
(-)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-N1976-1mg
|
MedChemexpress LLC
|
(+)-(3R,8S)-Falcarindiol [CAS 225110-25-8]
|
|
Cancer-programmed cell death
|
|
HY-N1976-10mg
|
MedChemexpress LLC
|
(+)-(3R,8S)-Falcarindiol [CAS 225110-25-8]
|
|
Cancer-programmed cell death
|
|
HY-N1976-5mg
|
MedChemexpress LLC
|
(+)-(3R,8S)-Falcarindiol [CAS 225110-25-8]
|
|
Cancer-programmed cell death
|
|
HY-N1976-1mL
|
MedChemexpress LLC
|
(+)-(3R,8S)-Falcarindiol [CAS 225110-25-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-112789-10mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
HY-112789-100mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
HY-112789-25mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
HY-112789-5mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
HY-112789-50mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
HY-112789-1mL
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-134978A-1mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978A-10mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978A-100mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978A-25mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978A-5mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-134978A-50mg
|
MedChemexpress LLC
|
(+)SHIN2
|
|
Cancer-programmed cell death
|
|
HY-126042-10mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-126042-100mg
|
MedChemexpress LLC
|
(�)-Lisofylline [CAS 6493-06-7]
|
|
Metabolism-sugar/lipid metabolism
|
|